107 related articles for article (PubMed ID: 21480471)
1. What's up with down syndrome and leukemia-A lot!
Taub JW; Ravindranath Y
Pediatr Blood Cancer; 2011 Jul; 57(1):1-3. PubMed ID: 21480471
[No Abstract] [Full Text] [Related]
2. Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study.
Taga T; Shimomura Y; Horikoshi Y; Ogawa A; Itoh M; Okada M; Ueyama J; Higa T; Watanabe A; Kanegane H; Iwai A; Saiwakawa Y; Kogawa K; Yamanaka J; Tsurusawa M
Pediatr Blood Cancer; 2011 Jul; 57(1):36-40. PubMed ID: 21557456
[TBL] [Abstract][Full Text] [Related]
3. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
4. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.
Creutzig U; Reinhardt D; Diekamp S; Dworzak M; Stary J; Zimmermann M
Leukemia; 2005 Aug; 19(8):1355-60. PubMed ID: 15920490
[TBL] [Abstract][Full Text] [Related]
5. Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols.
Khattab TM; Atra AA; Elimam NA; Kassar A; Zayed A; Baothman A
Saudi Med J; 2008 May; 29(5):776-7. PubMed ID: 18454233
[No Abstract] [Full Text] [Related]
6. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
Kudo K; Kojima S; Tabuchi K; Yabe H; Tawa A; Imaizumi M; Hanada R; Hamamoto K; Kobayashi R; Morimoto A; Nakayama H; Tsuchida M; Horibe K; Kigasawa H; Tsukimoto I;
J Clin Oncol; 2007 Dec; 25(34):5442-7. PubMed ID: 18048827
[TBL] [Abstract][Full Text] [Related]
7. [Cure of acute myeloblastic leukemia in a child with Down syndrome and tetralogy of Fallot].
Balcar-Boroń A; Nowaczyk-Michalak A; Graduszewska-Czerebiej K
Wiad Lek; 1992 Mar; 45(5-6):220-3. PubMed ID: 1455866
[No Abstract] [Full Text] [Related]
8. Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group.
Kawasaki H; Isoyama K; Eguchi M; Hibi S; Kinukawa N; Kosaka Y; Oda T; Oda M; Nishimura S; Imaizumi M; Okamura T; Hongo T; Okawa H; Mizutani S; Hayashi Y; Tsukimoto I; Kamada N; Ishii E
Blood; 2001 Dec; 98(13):3589-94. PubMed ID: 11739161
[TBL] [Abstract][Full Text] [Related]
9. Lung toxicity following fludarabine, cytosine arabinoside and mitoxantrone (flan) treatment for acute leukemia.
Salvucci M; Zanchini R; Molinari A; Zuffa E; Poletti V; Poletti G; Zaccaria A
Haematologica; 2000 Jul; 85(7):769-70. PubMed ID: 10897135
[No Abstract] [Full Text] [Related]
10. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U
Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261
[TBL] [Abstract][Full Text] [Related]
11. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
[TBL] [Abstract][Full Text] [Related]
12. [Recurrence or therapeutic resistance of acute myelogenous leukemia. Effect of mitoxantrone and cytosine arabinoside].
Evensen SA; Brinch L; Wisløff F
Tidsskr Nor Laegeforen; 1989 Jun; 109(19-21):2004-6. PubMed ID: 2749689
[TBL] [Abstract][Full Text] [Related]
13. Regimen containing perarubicin for the treatment of newly diagnosed young patients with acute myeloid leukemia.
Zhong LY; Li QH; Huang ZL; Lin W; Lu ZS; Weng JY; Wu SJ; Du X
Ai Zheng; 2009 Jun; 28(6):619-25. PubMed ID: 19635200
[TBL] [Abstract][Full Text] [Related]
14. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
Paśnicki M
Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
[No Abstract] [Full Text] [Related]
15. [Myelogenous leukemia in children. ANLL9205 study by Children's Cancer and Leukemia Study Group (CCLSG)].
Mimaya J; Horikoshi Y; Shimizu H; Maeda H; Koizumi S; Kawakami K; Watanabe A; Utsumi J; Kikuta A; Oka T; Mugishima H; Kawamura N; Gushiken T; Ohta S; Yamamura Y; Ishida Y; Sekine I; Okada N; Fujimoto T
Rinsho Ketsueki; 1997 Feb; 38(2):100-7. PubMed ID: 9059063
[TBL] [Abstract][Full Text] [Related]
16. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
Rigacci L; Carrai V; Nassi L; Alterini R; Longo G; Bernardi F; Bosi A
Cancer; 2005 Mar; 103(5):970-7. PubMed ID: 15666323
[TBL] [Abstract][Full Text] [Related]
17. Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience.
Kohrt HE; Patel S; Ho M; Owen T; Pollyea DA; Majeti R; Gotlib J; Coutre S; Liedtke M; Berube C; Alizadeh AA; Medeiros BC
Am J Hematol; 2010 Nov; 85(11):877-81. PubMed ID: 20872554
[TBL] [Abstract][Full Text] [Related]
18. High-dose Ara-C as a single-agent consolidation therapy in childhood acute myelogenous leukemia.
Lie SO; Berglund G; Gustafsson G; Jonmundsson G; Siimes M; Yssing M
Haematol Blood Transfus; 1990; 33():215-21. PubMed ID: 2138994
[No Abstract] [Full Text] [Related]
19. Thioguanine pharmacokinetics in induction therapy of children with acute myeloid leukemia.
Palle J; Frost BM; Petersson C; Hasle H; Hellebostad M; Kanerva J; Schmiegelow K; Lönnerholm G;
Anticancer Drugs; 2009 Jan; 20(1):7-14. PubMed ID: 19342996
[TBL] [Abstract][Full Text] [Related]
20. Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004.
Hassler A; Bochennek K; Gilfert J; Perner C; Schöning S; Creutzig U; Reinhardt D; Lehrnbecher T
Pediatr Blood Cancer; 2016 Jun; 63(6):1070-4. PubMed ID: 26814618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
